Geisinger developing AI solutions to detect, prevent high-burden diseases

Geisinger has tapped Medial EarlySign, an Israeli healthcare software company, to help the Danville, Pa.-based health system develop and deploy a suite of machine learning-powered digital solutions to identify patients at risk of high-burden diseases.

Advertisement

EarlySign will work closely with Geisinger’s Steele Institute for Health Innovation to implement the solutions. EarlySign’s LGI-Flag system will serve as a jumping off point for the partnership; the program analyzes medical data to help providers determine which patients are at risk for lower GI disorders.

By pooling EarlySign’s IT capabilities with Geisinger’s innovation initiatives, collection of patient data and roster of providers, the two organizations will be able to build upon the LGI-Flag system, applying the technology to other acute and chronic diseases.

More articles about AI:
GlaxoSmithKline poaches another biotech exec for AI team: 3 notes
Study: AI outperforms radiologists in managing thyroid nodules
Waystar acquires AI tech firm to streamline prior authorization

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.